Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...

Donald Trump previously said he would veto a national abortion ban because of the U.S. Supreme Court's 2022 ruling on Roe v. Wade.

The entire scope of the problem posed by so-called "forever chemicals" in Maryland schools is just beginning to come into view under a new federal law.

Since 2020, data shows Missouri’s Department of Corrections has paid out $68 million in settlements to contractors, inmates ...

Google, after three iterations, has finally gotten closer to a smartwatch with smarter smarts and a more holistic approach to ...

Researchers have developed a simple model system that can be used to break down fibrils -- the cause of numerous disorders including Alzheimer's and Parkinson's disease -- into their constituent ...

The federal government has tapped a panel of five experts to craft the path toward a universal pharmacare program. Dr. Nav ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

Robert F. Kennedy Jr. has promised to "make America healthy again." What does that actually mean? Here's everything he ...

Matt Gaetz, Donald Trump's polarizing pick to be the next Attorney General, has long been at the center of controversy.

Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug Nuvectis Pharma, Inc. (NASDAQ: NVCT) stock is trading lower after the company reported ...

In June, GSK released results from an interim analysis of the DREAMM-8 phase 3 head-to-head trial of Blenrep in combination with pomalidomide plus dexamethasone (PomDex), versus a standard of care, ...